TOKYO, June 1 (Reuters) - Japan's Shionogi & Co said on Monday the U.S. Food and Drug Administration has approved its oral ...

By Julie Steenhuysen CHICAGO, June 1 (Reuters) - Merck is in discussions with various global health authorities about making ...

An at-home pill against coronavirus halves the chance that people newly diagnosed with COVID-19 will land in the hospital or ...

The FDA on Monday approved the first medication for COVID-19 prevention that people can take after they have been exposed to ...

Plus, when it will actually be available in the U.S.

The drug showed promising results in an international study involving nearly 2,400 participants, and the U.S. Food and Drug ...

Having alleged officials actively sidelined warnings to push universal vaccination, Sen. Ron Johnson, R-Wisc., recently made ...

The FDA’s outside vaccine advisers overwhelmingly recommended Thursday that the agency direct manufacturers to base their 2026-2027 formulas on the dominant XFG Covid variant.

WASHINGTON (AP) — Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the ...

NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...